Operating Margin of Xeris Biopharma Holdings, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Xeris Biopharma Holdings, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Xeris Biopharma Holdings, Inc. Operating Margin for the quarter ending 30 Sep 2025 was 3.7%.
  • Xeris Biopharma Holdings, Inc. annual Operating Margin for 2021 was -232%, a 43% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Xeris Biopharma Holdings, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 3.7% +28% 01 Jul 2025 30 Sep 2025
Q2 2025 -4% +17% +81% 01 Apr 2025 30 Jun 2025
Q1 2025 -10% +16% +61% 01 Jan 2025 31 Mar 2025
Q4 2024 -17% +10% +38% 01 Oct 2024 31 Dec 2024
Q3 2024 -24% +8.2% +25% 01 Jul 2024 30 Sep 2024
Q2 2024 -20% +27% +57% 01 Apr 2024 30 Jun 2024
Q1 2024 -26% +28% +52% 01 Jan 2024 31 Mar 2024
Q4 2023 -27% +47% +64% 01 Oct 2023 31 Dec 2023
Q3 2023 -32% +84% +72% 01 Jul 2023 30 Sep 2023
Q2 2023 -47% +104% +69% 01 Apr 2023 30 Jun 2023
Q1 2023 -54% +146% +73% 01 Jan 2023 31 Mar 2023
Q4 2022 -74% +158% +68% 01 Oct 2022 31 Dec 2022
Q3 2022 -117% 01 Jul 2022 30 Sep 2022
Q2 2022 -151% 01 Apr 2022 30 Jun 2022
Q1 2022 -200% 01 Jan 2022 31 Mar 2022
Q4 2021 -232% 01 Oct 2021 31 Dec 2021

Xeris Biopharma Holdings, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2021 -232% +177% +43% 01 Jan 2021 31 Dec 2021
2020 -409% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.